The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Safety, efficacy, and tumor immune microenvironment changes with neoadjuvant chemotherapy and cemiplimab with or without alirocumab in stage 1B-3A non-small cell lung cancer.
 
Eziafa Oduah
Employment - Affordable Dental (I); Duke University
Consulting or Advisory Role - Johnson & Johnson; Roche/Genentech
Research Funding - OncoC4
 
Scott Antonia
Consulting or Advisory Role - Achilles Therapeutics; Guardian Bio; Immutep; Leap Therapeutics; Memgen; RAPT Therapeutics; Shoreline; Tubulis GmbH; xilis
Patents, Royalties, Other Intellectual Property - Oncolytic virus
Travel, Accommodations, Expenses - Achilles Therapeutics; Amgen; Celsius Therapeutics; RAPT Therapeutics
 
Jeffrey Clarke
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Corbus Pharmaceuticals; Genentech; Merck; Novartis; Pfizer; Sanofi; Spectrum Pharmaceuticals; Turning Point Therapeutics; Vivacitas Oncology
Speakers' Bureau - Amgen; AstraZeneca
Research Funding - Achilles Therapeutics (Inst); Adaptimmune (Inst); Array BioPharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cellular Biomedicine Group (Inst); Genentech (Inst); Grid Therapeutics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Spectrum Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen
(OPTIONAL) Uncompensated Relationships - Lung Cancer Initiative of North Carolina
 
Tom Stinchcombe
Consulting or Advisory Role - Abbvie; Boehringer Ingelheim; Coherus Biosciences; Gilead Sciences; Janssen Oncology; Pfizer; Takeda
Research Funding - Boehringer Ingelheim (Inst); Mirati Therapeutics (Inst); Nuvalent, Inc. (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Pfizer
Other Relationship - Genentech; GlaxoSmithKline; Merck; Seagen
 
Joel Rivera Concepcion
Consulting or Advisory Role - AstraZeneca; Bristol Myers Squibb Foundation; Genentech
Travel, Accommodations, Expenses - EMD Serono/Merck
 
Laura Alder
Consulting or Advisory Role - Foundation One Inc; OncoHost; Regeneron
Research Funding - BerGenBio; ORIC Pharmaceuticals
 
Cameron Oswalt
Honoraria - Cardinal Health
Consulting or Advisory Role - Cardinal Health
Travel, Accommodations, Expenses - Cardinal Health
 
Thomas D'Amico
Honoraria - Medtronic
Consulting or Advisory Role - Scanlan
 
David Harpole
Consulting or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
 
Betty Tong
No Relationships to Disclose
 
Hai Salfity
No Relationships to Disclose
 
Kunal Patel
No Relationships to Disclose
 
Kaitlin Bevers
No Relationships to Disclose
 
Matthew Hartwig
Consulting or Advisory Role - Biomedinnovations; CSL Behring; Lung Biongeineering; Paragonix; Trans Med
 
Xiaofei Wang
No Relationships to Disclose
 
Neal Ready
Honoraria - Jazz Pharmaceuticals
Consulting or Advisory Role - Abbvie; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Celgene; G1 Therapeutics; Jazz Pharmaceuticals; Johnson & Johnson/Janssen; Merck; Merck Serono; Novartis; Pfizer; Regeneron; Regeneron; Sanofi/Regeneron; Zai Lab
Speakers' Bureau - Bristol-Myers Squibb; Jazz Pharmaceuticals
Research Funding - Memgen (Inst); Merck; Regeneron (Inst)